These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16125625)

  • 1. Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs.
    Farkas S; Berzsenyi P; Kárpáti E; Kocsis P; Tarnawa I
    J Pharmacol Toxicol Methods; 2005; 52(2):264-73. PubMed ID: 16125625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silperisone: a centrally acting muscle relaxant.
    Farkas S
    CNS Drug Rev; 2006; 12(3-4):218-35. PubMed ID: 17227288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant.
    Ito T; Hori M; Furukawa K; Karasawa T; Kadokawa T
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):105-22. PubMed ID: 3839647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants.
    Simiand J; Keane PE; Biziere K; Soubrie P
    Arch Int Pharmacodyn Ther; 1989; 297():272-85. PubMed ID: 2567153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of centrally acting muscle relaxants on the intrathecal noradrenaline-induced facilitation of the flexor reflex mediated by group II afferent fibers in rats.
    Sakitama K
    Jpn J Pharmacol; 1993 Nov; 63(3):369-76. PubMed ID: 8107328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhancement of the muscle relaxant action of baclofen by glucocorticoids].
    Wakayama K
    Nihon Yakurigaku Zasshi; 1987 Feb; 89(2):81-90. PubMed ID: 3570106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.
    Kocsis P; Farkas S; Fodor L; Bielik N; Thán M; Kolok S; Gere A; Csejtei M; Tarnawa I
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1237-46. PubMed ID: 16126840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.
    Arshaduddin M; Al Kadasah S; Biary N; Al Deeb S; Al Moutaery K; Tariq M
    Behav Brain Res; 2004 Aug; 153(1):15-20. PubMed ID: 15219702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of centrally acting muscle relaxants on post-rotatory nystagmus in the rabbit.
    Ishikawa M; Nago M; Miyazaki H; Fukuda H
    Gen Pharmacol; 1989; 20(1):47-51. PubMed ID: 2707572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride.
    Morikawa K; Oshita M; Yamazaki M; Ohara N; Mizutani F; Kato H; Ito Y; Kontani H; Koshiura R
    Arzneimittelforschung; 1987 Mar; 37(3):331-6. PubMed ID: 3593447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mydeton: a centrally acting muscle relaxant drug from Gedeon Richter LTD].
    Kocsis P; Tarnawa I; Kovács G; Szombathelyi Z; Farkas S
    Acta Pharm Hung; 2002; 72(1):49-61. PubMed ID: 12426787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of NK433, a new centrally acting muscle relaxant.
    Sakitama K; Ozawa Y; Aoto N; Nakamura K; Ishikawa M
    Eur J Pharmacol; 1995 Jan; 273(1-2):47-56. PubMed ID: 7737318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some centrally acting muscle relaxants on spinal root potentials: a comparative study.
    Farkas S; Tarnawa I; Berzsenyi P
    Neuropharmacology; 1989 Feb; 28(2):161-73. PubMed ID: 2716970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
    Ochiai T; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):347-57. PubMed ID: 7327455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride.
    Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A
    Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma receptor modulation of the muscle relaxant action of eperisone.
    Hasegawa Y; Kaku S; Araki H; Otomo S
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):157-9. PubMed ID: 1353001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative characterisation of the centrally acting muscle relaxant RGH-5002 and tolperisone and of lidocaine based on their effects on rat spinal cord in vitro.
    Farkas S; Kocsis P; Bielik N
    Neurobiology (Bp); 1997; 5(1):57-8. PubMed ID: 9302697
    [No Abstract]   [Full Text] [Related]  

  • 18. An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine.
    Caron J; Kaye R; Wessel T; Halseth A; Kay G
    J Clin Pharm Ther; 2020 Aug; 45(4):774-782. PubMed ID: 32390248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.
    Quasthoff S; Möckel C; Zieglgänsberger W; Schreibmayer W
    CNS Neurosci Ther; 2008; 14(2):107-19. PubMed ID: 18482024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of beta-(p-chlorophenyl)-GABA (baclofen) on response to noxious stimuli (author's transl)].
    Yamamoto H; Kuki M; Ozaki M
    Nihon Yakurigaku Zasshi; 1977 Oct; 73(7):703-15. PubMed ID: 598782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.